1. Home
  2. XLO vs RGS Comparison

XLO vs RGS Comparison

Compare XLO & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • RGS
  • Stock Information
  • Founded
  • XLO 2016
  • RGS 1922
  • Country
  • XLO United States
  • RGS United States
  • Employees
  • XLO N/A
  • RGS N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • RGS Other Consumer Services
  • Sector
  • XLO Health Care
  • RGS Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • RGS Nasdaq
  • Market Cap
  • XLO 35.7M
  • RGS 70.8M
  • IPO Year
  • XLO 2021
  • RGS 1991
  • Fundamental
  • Price
  • XLO $0.75
  • RGS $28.48
  • Analyst Decision
  • XLO Buy
  • RGS
  • Analyst Count
  • XLO 2
  • RGS 0
  • Target Price
  • XLO $3.00
  • RGS N/A
  • AVG Volume (30 Days)
  • XLO 946.5K
  • RGS 25.2K
  • Earning Date
  • XLO 11-06-2025
  • RGS 11-05-2025
  • Dividend Yield
  • XLO N/A
  • RGS N/A
  • EPS Growth
  • XLO N/A
  • RGS 20.23
  • EPS
  • XLO N/A
  • RGS 46.10
  • Revenue
  • XLO $15,001,000.00
  • RGS $210,134,000.00
  • Revenue This Year
  • XLO $982.12
  • RGS N/A
  • Revenue Next Year
  • XLO N/A
  • RGS N/A
  • P/E Ratio
  • XLO N/A
  • RGS $0.65
  • Revenue Growth
  • XLO 536.45
  • RGS 3.52
  • 52 Week Low
  • XLO $0.62
  • RGS $15.00
  • 52 Week High
  • XLO $1.70
  • RGS $30.29
  • Technical
  • Relative Strength Index (RSI)
  • XLO 60.31
  • RGS 70.60
  • Support Level
  • XLO $0.71
  • RGS $22.00
  • Resistance Level
  • XLO $0.78
  • RGS $30.29
  • Average True Range (ATR)
  • XLO 0.04
  • RGS 1.60
  • MACD
  • XLO 0.01
  • RGS 0.54
  • Stochastic Oscillator
  • XLO 64.03
  • RGS 81.20

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: